Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes.
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.
Prediction of disability progression in fingolimod-treated patients.
Glucosamine modulates T cell differentiation through downregulating N-linked glycosylation of CD25.
The ethics of placebo controlled clinical trials in NMO - A balance of risks.
CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
Visual outcome following optic neuritis: A 5-year review.
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation.
Sexual function in women with multiple sclerosis.
Fatigue, depression, and physical impairment in multiple sclerosis.
7 tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide.
Compare before deciding. Treatment of relapsing-remitting multiple sclerosis.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
A nexus between lipids and multiple sclerosis?
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.
Telemedicine for Monitoring MS Activity and Progression.
Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis.
Fertility treatment in spinal cord injury and other neurologic disease.
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
387
388
389
390
391
392
393
394
395
…
next ›
last »